Moderna

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague,…

By Arthur Allen A small percentage of Americans got the most recent covid-19 booster shot, and even fewer probably realize the federal government is preparing to recommend yet…

A health-care worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, Jan. 26, 2022.Vanessa Leroy |…

A pharmacist prepares to administer Covid-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center in Chicago, Illinois,…

A nurse prepares doses of the Pfizer vaccine on Dec. 30, 2021, during a COVID-19 vaccination event at Josephine's Southern Cooking in Chatham, Illinois.Brian Cassella | Tribune News Service…

Nikos Pekiaridis | Nurphoto | Getty ImagesModerna on Wednesday said it struck a deal with Chinese officials to research, develop and manufacture messenger RNA medicines in the country,…

A vial and a medical syringe seen displayed in front of the U.S. Food and Drug Administration and Moderna biotechnology company's logos.Pavlo Gonchar | LightRocket | Getty ImagesModerna on…

A pharmacist prepares to administer COVID-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center on September 09, 2022 in…

Despite these historic approvals, GSK's supremacy in the unexplored RSV vaccine area is threatened by Pfizer, which is aggressively pursuing market share for its own RSV vaccine Abrysvo…

Asbe | Istock | Getty ImagesModerna's experimental cancer vaccine, used in combination with Merck's Keytruda, reduced the risk of the most deadly form of skin cancer spreading to other parts…